Page last updated: 2024-08-23

paroxetine and Disease Exacerbation

paroxetine has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dadić-Hero, E; Grahovac, T; Petranović, D; Ružić, K; Valković, T	1
Cadet, JL; Duan, W; Guo, Z; Jiang, H; Ladenheim, B; Mattson, MP; Xu, X	1
Amsterdam, JD; DeRubeis, RJ; Gallop, R; Hollon, SD; Leykin, Y; Shelton, RC	1

Trials

1 trial(s) available for paroxetine and Disease Exacerbation

Article	Year
Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of consulting and clinical psychology, 2007, Volume: 75, Issue:2 Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Disease Progression; Drug Resistance; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2007

Article

Year

Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression.

Journal of consulting and clinical psychology, 2007, Volume: 75, Issue:2

Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Disease Progression; Drug Resistance; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome

2007

Other Studies

2 other study(ies) available for paroxetine and Disease Exacerbation

Article	Year
Treatment strategy in schizophrenia combined with eating disorder. Psychiatria Danubina, 2011, Volume: 23, Issue:1 Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Apathy; Benzodiazepines; Comorbidity; Cooperative Behavior; Disease Progression; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Interdisciplinary Communication; Mobility Limitation; Olanzapine; Paroxetine; Schizophrenia; Schizophrenic Psychology; Social Isolation; Vitamin B 12; Weight Loss	2011
Paroxetine retards disease onset and progression in Huntingtin mutant mice. Annals of neurology, 2004, Volume: 55, Issue:4 Topics: Animals; Disease Progression; Female; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Paroxetine	2004

Article

Year

Treatment strategy in schizophrenia combined with eating disorder.

Psychiatria Danubina, 2011, Volume: 23, Issue:1

Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Apathy; Benzodiazepines; Comorbidity; Cooperative Behavior; Disease Progression; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Interdisciplinary Communication; Mobility Limitation; Olanzapine; Paroxetine; Schizophrenia; Schizophrenic Psychology; Social Isolation; Vitamin B 12; Weight Loss

2011

Paroxetine retards disease onset and progression in Huntingtin mutant mice.

Annals of neurology, 2004, Volume: 55, Issue:4

Topics: Animals; Disease Progression; Female; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Paroxetine

2004